TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 21 filers reported holding TRINITY BIOTECH PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,154 | -24.6% | 16,691 | 0.0% | 0.00% | – |
Q2 2023 | $16,110 | +2.7% | 16,691 | 0.0% | 0.00% | – |
Q1 2023 | $15,690 | -5.0% | 16,691 | +0.1% | 0.00% | – |
Q4 2022 | $16,509 | +1550.9% | 16,676 | +6030.9% | 0.00% | – |
Q1 2021 | $1,000 | -94.4% | 272 | -94.3% | 0.00% | – |
Q4 2020 | $18,000 | +100.0% | 4,772 | +11.7% | 0.00% | – |
Q3 2020 | $9,000 | +800.0% | 4,272 | +4172.0% | 0.00% | – |
Q1 2017 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | -97.6% | 100 | -95.6% | 0.00% | -100.0% |
Q2 2015 | $41,000 | -71.7% | 2,265 | -71.5% | 0.00% | -50.0% |
Q3 2014 | $145,000 | +5.1% | 7,950 | +32.4% | 0.00% | 0.0% |
Q2 2014 | $138,000 | -88.0% | 6,005 | -86.9% | 0.00% | -88.2% |
Q4 2013 | $1,154,000 | +75.4% | 45,890 | +51.7% | 0.02% | +30.8% |
Q3 2013 | $658,000 | +121.5% | 30,243 | +71.3% | 0.01% | +85.7% |
Q2 2013 | $297,000 | – | 17,651 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
Centaur Capital | 77,500 | $887,000 | 1.33% |
Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
RK Capital | 565,472 | $6,469,000 | 1.18% |
Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |